Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Effectiveness, Safety, and Immunogenicity of Chikungunya Vaccination During an Epidemic Period: an Ambispective Study in Réunion Island and French Guiana.

NCT06928753 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de la Réunion as lead sponsor.

NCT NCT06928753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06928753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Effectiveness, Safety, and Immunogenicity of Chikungunya Vaccination During an Epidemic Period: an Ambispective Study in Réunion Island and French Guiana.
Lead sponsor
Centre Hospitalier Universitaire de la Réunion
Phase
Phase 4
Overall status
Recruiting
Start date
April 18, 2025
Completion date
December 31, 2027
Enrollment
1,505 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chikungunya virus infection